• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA gives public access to Global Unique Device Identification Database (GUDID)

FDA gives public access to Global Unique Device Identification Database (GUDID)

May 19, 2015 By MassDevice Contributors Network

Halloran logo

By Angela Brown

The Food and Drug Administration (FDA) has met yet another 2015 objective in May by making the Global Unique Device Identification Database (GUDID) publicly available.  This database is a requirement of the 2013 FDA Final Rule for a Unique Device Identification (UDI) System. The GUDID (pronounced “good-ID”) contains important information to trace medical devices sold in the United States through the entire distribution channel from the manufacturer to the patient.  It is the expectation that through the implementation and realization of this program will provide a means to improve adverse event trending, handling of product recalls and post market surveillance. 

Unique Device Identifier (UDI)

The UDI for a medical device has two components:

  • Device Identifier (DI) – a fixed numeric or alphanumeric code identifying the device and labeler of the device  and
  • Product Identifier (PI) – a variable numeric or alphanumeric code identifying the manufacturing information of the device.

Although the UDI consists of two parts, the GUDID only stores the DI. This UDI is to be affixed to labeling, packaging, and in some cases, the device itself in human and machine readable formats by the “labeler” defined as

  • “Any person who causes a label to be applied to a device with the intent that the device will be commercially distributed without any intended subsequent replacement or modification of the label; and
  • Any person who causes the label of a device to be replaced or modified with the intent that the device will be commercially distributed without any subsequent replacement or modification of the label, except that the addition of the name of, and contact information for, a person who distributes the device, without making any other changes to the label, is not a modification for the purposes of determining whether a person is a labeler. 21 CFR 801.3.”

The GUDID Database

On May 14, 2015, the FDA launched public access to the GUDID. This database is currently in beta mode, user friendly, and open for comment and suggestions.  The database contains the information provided by labelers required to submit data by the September 24, 2014 compliance date for labeling of Class III devices. The immediate capabilities of the database are basic searches and downloads for a limited range of products.  

Over the next five (5) years labelers will be required to phase in remaining devices to occur on two parallel paths; labeling and direct marking as shown in the table below. 

Table 1:  Compliance Dates for UDI Requirements

Device

Label/GUDID Data Entry
Compliance Date

Direct Mark*
Compliance Date

Class III Life Supporting, Life Sustaining

September 24, 2014

September 24, 2015

Implantable (Class II, Class I, unclassified)

September 24, 2015

N/A

Life Supporting/Life Sustaining (Class II, Class I, unclassified)

September 24, 2015

September 24, 2015

Class III (non Life Supporting/Life Sustaining)

September 24, 2014

September 24, 2016

Class II

September 24, 2016

September 24, 2018

Class I or unclassified

September 24, 2018

September 24, 2020

*Direct marking is where the UDI is placed directly on the device.  The Direct mark is required for devices that are intended to be reused and intended to be reprocessed before each use.  This is in addition to the labeling requirements.

By 2020 the Agency will have a complete database for existing devices, widening the product ranges and increasing usability.   The GUDID guidance provides details on how to input and edit the data; describes roles and responsibilities; defines key terms and acronyms; and offers flowcharts and visual examples in order to aid the labeler in a successful submission.  Where there are many items to consider within the process, one main element of the guidance that stands out is the requirement to comply with 21 CFR Part 11 for record retention. 

Conclusion

The public launch of the GUDID gives FDA, industry, health care providers, and patients access to device information and labeler of the device in one accessible location.  As part of the UDI system, this database will provide a means to analyze trends for problem devices more quickly; to obtain post market surveillance data for submissions; to improve device recall management; and for global recognition of a medical device identification database. 

For more information please contact Angela Brown, Senior Consultant, Halloran Consulting Group at [email protected].

Filed Under: Blog, Food & Drug Administration (FDA), News Well Tagged With: Halloran Consulting Group

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy